Allfudo'n Llwyddiannus — 

Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol

BACKGROUND: The efficacy and safety of Lisdexamfetamine dimesylate (LDX) in the treatment of moderate to severe binge eating disorder (BED) has been demonstrated in multiple randomised clinical trials. Despite this, little is known about how LDX acts to improve binge eating symptoms. This study aims...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Eat Disord
Prif Awduron: Griffiths, Kristi R., Yang, Jenny, Touyz, Stephen W., Hay, Phillipa J., Clarke, Simon D., Korgaonkar, Mayuresh S., Gomes, Linette, Anderson, Gail, Foster, Sheryl, Kohn, Michael R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2019
Pynciau:
Study Protocol
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6621979/
https://ncbi.nlm.nih.gov/pubmed/31333843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40337-019-0253-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg